专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20120253207A1 HEART FAILURE MONITORING 审中-公开
标题翻译：心力衰竭监测
公开(公告)号：US20120253207A1
公开(公告)日：2012-10-04
申请号：US13436408
申请日：2012-03-30
申请人： Shantanu Sarkar , Jodi L. Redemske , Eduardo N. Warman , Douglas A. Hettrick , Kevin T. Ousdigian
发明人： Shantanu Sarkar , Jodi L. Redemske , Eduardo N. Warman , Douglas A. Hettrick , Kevin T. Ousdigian
IPC分类号： A61B5/0205
CPC分类号： A61B5/0006 , A61B5/0004 , A61B5/7275 , G06F19/3418 , G16H40/40 , G16H50/30
摘要： Techniques for transmitting diagnostic information stored in an implantable medical device (IMD) based on patient hospitalization are described. For example, the IMD may transmit higher resolution diagnostic information to a clinician and/or an external device during a hospitalization period to aid the clinician in evaluating heart failure treatment and when discharge is proper. This higher resolution diagnostic information may include one or more patient metrics automatically generated and transmitted by the IMD at least once every two hours. During a post-hospitalization period, the IMD may transmit lower resolution diagnostic information to a clinician that indicates a risk level of re-hospitalization. The lower resolution diagnostic information may include the risk level and/or patient metrics once a day, for example. In this manner, the IMD transmitted diagnostic information may be tailored to the specific heart failure monitoring needed by the patient.
摘要翻译：描述了基于患者住院时间传送存储在可植入医疗装置（IMD）中的诊断信息的技术。例如，IMD可以在住院期间向临床医师和/或外部设备传送更高分辨率的诊断信息，以帮助临床医师评价心力衰竭治疗以及放电是否合适。该更高分辨率的诊断信息可以包括由IMD自动生成和发送的至少每两小时一次的一个或多个患者度量。在住院后期间，IMD可以向临床医生传递较低分辨率的诊断信息，指示重新住院的风险水平。例如，较低分辨率诊断信息可以包括一天一次的风险水平和/或患者度量。以这种方式，IMD传输的诊断信息可以针对患者所需的特定心力衰竭监测。

2. 发明授权

US10542887B2 Heart failure monitoring 有权
公开(公告)号：US10542887B2
公开(公告)日：2020-01-28
申请号：US13436408
申请日：2012-03-30
申请人： Shantanu Sarkar , Jodi L. Redemske , Eduardo N. Warman , Douglas A. Hettrick , Kevin T. Ousdigian
发明人： Shantanu Sarkar , Jodi L. Redemske , Eduardo N. Warman , Douglas A. Hettrick , Kevin T. Ousdigian
IPC分类号： A61B5/02 , A61B5/00
摘要： Techniques for transmitting diagnostic information stored in an implantable medical device (IMD) based on patient hospitalization are described. For example, the IMD may transmit higher resolution diagnostic information to a clinician and/or an external device during a hospitalization period to aid the clinician in evaluating heart failure treatment and when discharge is proper. This higher resolution diagnostic information may include one or more patient metrics automatically generated and transmitted by the IMD at least once every two hours. During a post-hospitalization period, the IMD may transmit lower resolution diagnostic information to a clinician that indicates a risk level of re-hospitalization. The lower resolution diagnostic information may include the risk level and/or patient metrics once a day, for example. In this manner, the IMD transmitted diagnostic information may be tailored to the specific heart failure monitoring needed by the patient.

3. 发明申请

US20120109243A1 HEART FAILURE MONITORING AND NOTIFICATION 审中-公开
标题翻译：心脏失效监测和通报
公开(公告)号：US20120109243A1
公开(公告)日：2012-05-03
申请号：US12914836
申请日：2010-10-28
申请人： Douglas A. Hettrick , Shantanu Sarkar , Kevin T. Ousdigian
发明人： Douglas A. Hettrick , Shantanu Sarkar , Kevin T. Ousdigian
IPC分类号： A61N1/365 , A61B5/0402
CPC分类号： A61B5/7275 , A61B5/0022 , A61B5/0031 , A61B5/0205 , A61B5/02405 , A61B5/046 , A61B5/0464 , A61B5/0538 , A61B5/1118 , A61B5/4875 , A61B5/686 , G06F19/3418 , G16H50/30
摘要： Techniques for generating a heart failure risk score with detected patient metrics are described. An implantable medical device (IMD) may collect and store patient data regarding therapy use statistics, thoracic impedance, heart rate, patient activity, and other patient metrics. Based on the number of patient metrics exceeding their respective metric thresholds, the IMD may automatically generate a risk score that indicates the likelihood that the patient will suffer from heart failure. The risk score may identify a patient as requiring immediate medical attention to reduce the risk of heart failure. The IMD may push an alert of the heart failure risk score to a clinician, and the clinician may review the patient metric data on an external device. In some examples, a clinician may prioritize patient treatment with a presented list ranking patients with the most severe heart failure risk scores.
摘要翻译：描述用于产生具有检测到的患者度量的心力衰竭风险评分的技术。可植入医疗装置（IMD）可以收集和存储关于治疗使用统计，胸部阻抗，心率，患者活动和其他患者度量的患者数据。基于超过其各自度量阈值的患者指标的数量，IMD可以自动产生指示患者将患有心力衰竭的可能性的风险评分。风险评分可能会确定患者需要立即就医以减少心力衰竭的风险。 IMD可以向临床医生推荐心力衰竭风险评分的警报，并且临床医生可以在外部设备上检查患者度量数据。在一些例子中，临床医生可以用列出的列表对患者治疗进行优先级排序，以评估患有最严重的心力衰竭风险评分的患者。

4. 发明授权

US08744560B2 Electrogram summary 有权
标题翻译：电图概要
公开(公告)号：US08744560B2
公开(公告)日：2014-06-03
申请号：US13250676
申请日：2011-09-30
申请人： Bruce D. Gunderson , Karen J. Kleckner , Kevin T. Ousdigian , Amisha S. Patel , Julian Sanchez
发明人： Bruce D. Gunderson , Karen J. Kleckner , Kevin T. Ousdigian , Amisha S. Patel , Julian Sanchez
IPC分类号： A61B5/0456
CPC分类号： A61N1/37247 , A61B5/0031 , A61B5/044 , A61B5/0452 , A61B5/0464 , A61B5/0468 , A61B5/076 , A61B5/7217 , A61B5/7264
摘要： The present disclosure is directed to generating and displaying an electrogram (EGM) summary for use by physicians or other clinicians. An implantable medical device (IMD) transmits EGM signal data for a number of cardiac episodes to an external computing device. The external computing device selects a subset of the cardiac episodes for which information or images are displayed to the user. In various examples, cardiac episodes may be selected for display based at least in part on a retrospective analysis classification of the cardiac episode.
摘要翻译：本公开涉及生成和显示用于医生或其他临床医师使用的电描记图（EGM）摘要。可植入医疗装置（IMD）向多个心脏发作的EGM信号数据发送到外部计算装置。外部计算设备选择向用户显示信息或图像的心脏发作的子集。在各种示例中，可以至少部分地基于心脏发作的回顾性分析分类来选择心脏发作来进行显示。

5. 发明授权

US08229559B2 Evaluation of implantable medical device data 有权
标题翻译：可植入医疗器械数据的评估
公开(公告)号：US08229559B2
公开(公告)日：2012-07-24
申请号：US12837320
申请日：2010-07-15
申请人： Hendrikus A. Westendorp , Cygni Chan , Amisha S. Patel , Denise Dirnberger , Jean K. Ringold , Kevin T. Ousdigian , Robert B. Trojan , Nelson H. Soken , Karen J. Kleckner
发明人： Hendrikus A. Westendorp , Cygni Chan , Amisha S. Patel , Denise Dirnberger , Jean K. Ringold , Kevin T. Ousdigian , Robert B. Trojan , Nelson H. Soken , Karen J. Kleckner
IPC分类号： A61N1/00
CPC分类号： A61N1/37247 , A61B5/0031 , A61B5/0452 , A61B5/7217 , A61B5/7475 , A61N1/3962 , G06F19/00 , G06F19/3481 , G16H40/40
摘要： A system includes an episode classification module and a data retrieval module. The episode classification module receives electrograms (EGMs) from N implantable medical devices (IMDs) and determines whether the EGMs are associated with deliveries of therapy by the N IMDs. The episode classification module analyzes at least some of the EGMs and determines whether the deliveries or non-deliveries of therapy by the IMDs were appropriate. The data retrieval module receives a request from a computing device, via a network, that indicates at least two groups of the N IMDs. The data retrieval module provides to the computing device via the network, in response to the request, data for presentation to a user that indicates for each of the groups, at least one of how many of the one or more deliveries or non-deliveries were appropriate, or how many of the one or more deliveries or non-deliveries were inappropriate.
摘要翻译：系统包括剧集分类模块和数据检索模块。情节分类模块从N个植入式医疗设备（IMD）接收电描记图（EGM），并确定EGM是否与N IMD的治疗交付相关联。情节分类模块分析至少一些EGMs，并确定IMD的分娩或非递送治疗是否合适。数据检索模块经由网络从计算设备接收指示N个IMD的至少两组的请求。数据检索模块经由网络向计算设备提供响应于该请求的用于呈现给用户的用于指示每个组的数据的数据，所述一个或多个传送或非传送中的至少一个是适当的，或者一个或多个交付或不交付是不适当的。

6. 发明授权

US08862212B2 Aggregating cardiac resynchronization therapy data 有权
标题翻译：聚集心脏再同步治疗数据
公开(公告)号：US08862212B2
公开(公告)日：2014-10-14
申请号：US13316177
申请日：2011-12-09
申请人： Helen W. Otto , Kevin T. Ousdigian , Julian Sanchez , Sean R. Landman , Robert W. Stadler
发明人： Helen W. Otto , Kevin T. Ousdigian , Julian Sanchez , Sean R. Landman , Robert W. Stadler
IPC分类号： A61B5/0402 , G06F19/00
CPC分类号： G06F19/3443 , G06F19/00 , G16H50/70
摘要： Cardiac resynchronization therapy (CRT) performance data for a number of patients in which an implantable medical device (IMD) is implanted is aggregated and reports of the aggregated data are generated, e.g., for review by organizations or individual clinicians treating the patients. In one example, a method includes collecting CRT performance data correlated to cardiac rhythm event data for a first group of patients in which an IMD configured to deliver CRT is implanted, aggregating, with a computing device, the CRT performance data correlated to the cardiac rhythm event data for a second group of patients from among the first group of patients, and generating, with the computing device, a report comprising the aggregation of the CRT performance data correlated to the cardiac rhythm event data for the second group of patients.
摘要翻译：对植入了植入式医疗装置（IMD）的许多患者的心脏再同步治疗（CRT）性能数据进行聚合，并且生成聚合数据的报告，例如用于治疗患者的组织或个体临床医师的审查。在一个示例中，一种方法包括收集与其中植入用于递送CRT的IMD相关的第一组患者的与心律事件数据相关的CRT性能数据，与计算设备聚合与心律相关的CRT性能数据生成来自第一组患者的第二组患者的事件数据，并且与计算设备一起生成包括与第二组患者的心律事件数据相关的CRT性能数据的聚集的报告。

7. 发明申请

US20130085403A1 ELECTROGRAM SUMMARY 有权
标题翻译：电机概要
公开(公告)号：US20130085403A1
公开(公告)日：2013-04-04
申请号：US13250515
申请日：2011-09-30
申请人： Bruce D. Gunderson , Karen J. Kleckner , Kevin T. Ousdigian , Amisha S. Patel , Julian Sanchez
发明人： Bruce D. Gunderson , Karen J. Kleckner , Kevin T. Ousdigian , Amisha S. Patel , Julian Sanchez
IPC分类号： A61B5/044 , A61B5/046 , A61B5/0464
CPC分类号： A61B5/044 , A61B5/046 , A61B5/0464 , A61B5/7217
摘要： The present disclosure is directed to an electrogram summary. In various examples, a subset of cardiac episodes are selected and displayed based on a set of summary rules. The subset of cardiac episodes includes at least one episode from each of a plurality of episode categories with at least one cardiac episode. In some examples, the order in which the cardiac episodes selected are displayed is based on the set of summary rules. The electrogram summary may include images or information regarding each of the selected cardiac episodes.
摘要翻译：本公开涉及电描记图。在各种示例中，基于一组汇总规则来选择和显示心脏发作的一个子集。心脏发作的子集包括来自具有至少一个心脏发作的多个发作类别中的每一个的至少一个情节。在一些示例中，显示所选择的心脏发作的顺序是基于汇总规则的集合。电描记图可以包括关于所选心脏发作中的每一个的图像或信息。

8. 发明申请

US20110172727A1 REDUCING INAPPROPRIATE DELIVERY OF THERAPY FOR SUSPECTED NON-LETHAL ARRHYTHMIAS 有权
标题翻译：减少不合理的非精神病人的治疗方法
公开(公告)号：US20110172727A1
公开(公告)日：2011-07-14
申请号：US13053625
申请日：2011-03-22
申请人： Kevin T. Ousdigian
发明人： Kevin T. Ousdigian
IPC分类号： A61N1/365
CPC分类号： A61N1/37252 , A61B5/0464 , A61B5/7264 , A61N1/3621 , A61N1/3956 , A61N1/3987
摘要： An implantable medical device (IMD) identifies suspected non-lethal ventricular arrhythmia, and takes one or more actions in response to the identification to avoid or delay delivery of a defibrillation or cardioversion shock. The IMD employs number of intervals to detect (NID) thresholds for detection of ventricular arrhythmias. When a NID threshold is met, the IMD determines whether the ventricular rhythm is a suspected non-lethal rhythm despite satisfying a NID threshold. In some embodiments, the IMD increases the NID threshold, i.e., extends the time for detection, in response to identifying a rhythm as a suspected non-lethal rhythm, and monitors subsequent ventricular beats to determine if the increased NID threshold is met before detecting a ventricular arrhythmia and delivering therapy. The IMD can determine whether a rhythm is a suspected non-lethal arrhythmia by, for example, comparing the median ventricular cycle length (VCL) to the median atrial cycle length (ACL).
摘要翻译：植入式医疗器械（IMD）识别疑似非致死性室性心律失常，并采取一项或多项行动来回应识别，以避免或延迟除颤或复律性休克的传播。 IMD采用间隔数来检测（NID）阈值以检测室性心律失常。当满足NID阈值时，即使满足NID阈值，IMD确定心室节律是否是怀疑的非致命节律。在一些实施例中，响应于将节律识别为怀疑非致命节律，IMD增加NID阈值，即扩展检测时间，并且监测随后的心室搏动以确定在检测到之前是否满足增加的NID阈值室性心律失常和输送治疗。 IMD可以通过例如比较心室中心周期长度（VCL）与中位心房周期长度（ACL）来确定节律是否是怀疑是非致死性心律失常。

9. 发明授权

US06718204B2 Method and apparatus to control delivery of high-voltage and anti-tachy pacing therapy in an implantable medical device 有权
标题翻译：用于控制可植入医疗装置中的高电压和抗速度起搏治疗递送的方法和装置
公开(公告)号：US06718204B2
公开(公告)日：2004-04-06
申请号：US09918224
申请日：2001-07-30
申请人： Paul J. DeGroot , Kevin T. Ousdigian , Vasant Padmanabhan , Paul Krause , Vinod Sharma
发明人： Paul J. DeGroot , Kevin T. Ousdigian , Vasant Padmanabhan , Paul Krause , Vinod Sharma
IPC分类号： A61N108
CPC分类号： A61N1/3622 , A61N1/3688 , A61N1/3925 , A61N1/3956 , A61N1/3962 , A61N1/3987
摘要： A system and method for delivering both anti-tachy pacing (ATP) therapy and high-voltage shock therapy in response to detection of abnormal cardiac rhythms is disclosed. The system controls the time between delivering ATP therapy and the charging of high-voltage capacitors in preparation for shock delivery based on a predetermined set of criteria. In one embodiment, the inventive system operates in an ATP During Capacitor Charging (ATP-DCC) mode wherein all, or substantially all, of the ATP therapy is delivered during charging of the high-voltage capacitors. Based on evaluation of the predetermined set of criteria, the system may switch to an additional ATP Before Capacitor Charging (ATP-BCC) mode, wherein substantially all of the ATP therapy is delivered prior to charging of the high-voltage capacitor. According to one aspect of the invention, the predetermined set of criteria is based, at least in part, on the effectiveness of previously-delivered ATP therapy.
摘要翻译：公开了一种用于响应于异常心律的检测而提供抗起搏起搏（ATP）治疗和高压休克疗法的系统和方法。该系统基于预定的一组标准来控制ATP治疗与高压电容器的充电之间的时间，以准备冲击输送。在一个实施例中，本发明的系统在ATP电容器充电（ATP-DCC）模式下工作，其中在高压电容器充电期间全部或基本上全部ATP治疗被递送。基于对预定标准集合的评估，系统可以切换到在电容器充电（ATP-BCC）模式之外的另外的ATP，其中在高压电容器充电之前基本上全部ATP治疗被递送。根据本发明的一个方面，预定的一组标准至少部分地基于先前传递的ATP治疗的有效性。

10. 发明授权

US08594786B2 Reducing inappropriate delivery of therapy for suspected non-lethal arrhythmias 有权
公开(公告)号：US08594786B2
公开(公告)日：2013-11-26
申请号：US13053625
申请日：2011-03-22
申请人： Kevin T. Ousdigian
发明人： Kevin T. Ousdigian
IPC分类号： A61N1/365
CPC分类号： A61N1/37252 , A61B5/0464 , A61B5/7264 , A61N1/3621 , A61N1/3956 , A61N1/3987
摘要： An implantable medical device (IMD) identifies suspected non-lethal ventricular arrhythmia, and takes one or more actions in response to the identification to avoid or delay delivery of a defibrillation or cardioversion shock. The IMD employs number of intervals to detect (NID) thresholds for detection of ventricular arrhythmias. When a NID threshold is met, the IMD determines whether the ventricular rhythm is a suspected non-lethal rhythm despite satisfying a NID threshold. In some embodiments, the IMD increases the NID threshold, i.e., extends the time for detection, in response to identifying a rhythm as a suspected non-lethal rhythm, and monitors subsequent ventricular beats to determine if the increased NID threshold is met before detecting a ventricular arrhythmia and delivering therapy. The IMD can determine whether a rhythm is a suspected non-lethal arrhythmia by, for example, comparing the median ventricular cycle length (VCL) to the median atrial cycle length (ACL).

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式